A.K. Burnett

750 total citations
22 papers, 449 citations indexed

About

A.K. Burnett is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, A.K. Burnett has authored 22 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 6 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in A.K. Burnett's work include Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Retinoids in leukemia and cellular processes (4 papers). A.K. Burnett is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Retinoids in leukemia and cellular processes (4 papers). A.K. Burnett collaborates with scholars based in United Kingdom, Canada and Italy. A.K. Burnett's co-authors include Keith Wheatley, Giovanna Meloni, B. Björkstrand, Vittorio Rizzoli, Norbert Claude Gorin, Myriam Labopin, M Körbling, E. P. Alessandrino, P Hervé and Angelo Michele Carella and has published in prestigious journals such as Blood, FEBS Letters and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A.K. Burnett

20 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.K. Burnett United Kingdom 11 327 127 101 95 56 22 449
Victor G. Gian United States 12 183 0.6× 155 1.2× 67 0.7× 85 0.9× 24 0.4× 25 440
Minako Iida Japan 7 290 0.9× 102 0.8× 82 0.8× 80 0.8× 56 1.0× 13 436
S A Evensen Norway 9 258 0.8× 119 0.9× 56 0.6× 36 0.4× 63 1.1× 13 451
Koichiro Ikuta Japan 10 429 1.3× 128 1.0× 139 1.4× 50 0.5× 90 1.6× 22 553
P. Dias Wickramanayake Germany 10 160 0.5× 149 1.2× 44 0.4× 60 0.6× 29 0.5× 22 400
E. Klumper Netherlands 11 238 0.7× 191 1.5× 353 3.5× 228 2.4× 140 2.5× 19 590
Catherine Garnett United Kingdom 8 234 0.7× 45 0.4× 66 0.7× 84 0.9× 27 0.5× 13 363
E. Pittermann Austria 8 253 0.8× 61 0.5× 48 0.5× 80 0.8× 21 0.4× 34 398
Patrizia Guglielmo Italy 10 218 0.7× 100 0.8× 42 0.4× 154 1.6× 22 0.4× 32 411
William R. Kiffmeyer United States 8 96 0.3× 75 0.6× 202 2.0× 174 1.8× 141 2.5× 9 446

Countries citing papers authored by A.K. Burnett

Since Specialization
Citations

This map shows the geographic impact of A.K. Burnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.K. Burnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.K. Burnett more than expected).

Fields of papers citing papers by A.K. Burnett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.K. Burnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.K. Burnett. The network helps show where A.K. Burnett may publish in the future.

Co-authorship network of co-authors of A.K. Burnett

This figure shows the co-authorship network connecting the top 25 collaborators of A.K. Burnett. A scholar is included among the top collaborators of A.K. Burnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.K. Burnett. A.K. Burnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grimwade, David, R P Gale, Robert K. Hills, et al.. (2003). The relationship between FLT3 mutation status: biological characteristics and outcome in patients with acute promyelocytic leukaemia.. Blood. 102(11). 3 indexed citations
2.
Watson, Maggie, Georgina Buck, Keith Wheatley, et al.. (2003). Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients. European Journal of Cancer. 40(7). 971–978. 66 indexed citations
3.
Mills, Ken, Amanda Gilkes, Marion Sweeney, et al.. (1998). Identification of a retinoic acid responsive aldoketoreductase expressed in HL60 leukaemic cells. FEBS Letters. 440(1-2). 158–162. 20 indexed citations
4.
Worwood, Mark, Jeremy D. Shearman, Daniel F. Wallace, et al.. (1997). A simple genetic test identifies 90% of UK patients with haemochromatosis. QUT ePrints (Queensland University of Technology). 6 indexed citations
5.
Grimwade, David, Hamish Walker, Keith Wheatley, et al.. (1997). What happens subsequently in AML when cytogenetic abnormalities persist at bone marrow harvest? Results of the 10th UK MRC AML Trial. Bone Marrow Transplantation. 19(11). 1117–1123. 22 indexed citations
6.
Grimwade, David, Keith Wheatley, G Harrison, et al.. (1996). Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.. Blood. 88. 2525–2525. 6 indexed citations
7.
Mills, Ken, et al.. (1996). Increasing methylation of the calcitonin gene during disease progression in sequential samples from CML patients. Leukemia Research. 20(9). 771–775. 15 indexed citations
8.
Owen, Gareth I., et al.. (1994). HLA-a-linked locus D6S265 is associated with increased susceptibility to common acute lymphoblastic leukaemia. European Journal of Cancer. 30. S2–S2.
9.
Cachia, P G, Christine Taylor, P. W. Thompson, et al.. (1994). Non-dysplastic myelodysplasia?. PubMed. 8(4). 677–81. 18 indexed citations
10.
Linch, David C., S.J. Proctor, Rajesh Chopra, et al.. (1993). Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation.. PubMed. 11(4). 307–11. 66 indexed citations
11.
Worman, C. P., A. Victor Hoffbrand, D W Milligan, et al.. (1993). Low-Dose Recombinant Alfa-2a-lnterferon: A Feasible Maintenance Therapy in Acute Myeloid Leukaemia in the Older Patient. Acta Haematologica. 89(1). 1–5. 8 indexed citations
12.
Dorak, M. Tevfik, Elizabeth Chalmers, Anne M. Sproul, et al.. (1993). MHC class III polymorphisms in selection of donors for BMT.. PubMed. 11(1). 37–41. 6 indexed citations
13.
Wheadon, Helen, et al.. (1993). Frequency of clonal remission in acute myeloid leukemia. International Journal of Gynecology & Obstetrics. 42(3). 321–321. 7 indexed citations
14.
Tait, Robert C., et al.. (1991). Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: Relationship to total body irradiation and graft-versus-host disease. International Journal of Radiation Oncology*Biology*Physics. 20(6). 1219–1227. 47 indexed citations
15.
Gorin, Norbert Claude, Myriam Labopin, Giovanna Meloni, et al.. (1991). Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).. PubMed. 5(10). 896–904. 95 indexed citations
16.
Chalmers, Elizabeth, Anne M. Sproul, Ken Mills, B Gibson, & A.K. Burnett. (1990). Use of the polymerase chain reaction to monitor engraftment following allogeneic bone marrow transplantation.. PubMed. 6(6). 399–403. 11 indexed citations
17.
Lough, Mary E., et al.. (1990). Parenteral nutrition in bone marrow transplantation. Clinical Nutrition. 9(2). 97–101. 29 indexed citations
18.
Burnett, A.K.. (1989). Current hematology and oncology. Fibrinolysis and Proteolysis. 3(2). 125–125.
19.
Janossy, George, Dario Campana, A.K. Burnett, et al.. (1988). Autologous bone marrow transplantation in acute lymphoblastic leukemia--preclinical immunologic studies.. PubMed. 2(8). 485–95. 19 indexed citations
20.
Williams, M.R., A.K. Burnett, & G. A. McDonald. (1982). The value of oral non-absorbed antibiotics in acute myeloid leukaemia. Journal of Infection. 5(1). 61–65. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor G. Gian Breakdown of academic impact, for papers by Minako Iida Breakdown of academic impact, for papers by S A Evensen Breakdown of academic impact, for papers by Koichiro Ikuta Breakdown of academic impact, for papers by P. Dias Wickramanayake Breakdown of academic impact, for papers by E. Klumper Breakdown of academic impact, for papers by Catherine Garnett Breakdown of academic impact, for papers by E. Pittermann Breakdown of academic impact, for papers by Patrizia Guglielmo Breakdown of academic impact, for papers by William R. Kiffmeyer
Rankless by CCL
2026